Dopamine Agonist News and Research

RSS
Impulse control disorders found to be more common in people taking Parkinson's drugs

Impulse control disorders found to be more common in people taking Parkinson's drugs

New drug may limit disease progression, provide better symptom relief to Parkinson's patients

New drug may limit disease progression, provide better symptom relief to Parkinson's patients

Increased sleepiness may necessitate cautious PD management

Increased sleepiness may necessitate cautious PD management

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

Impulse control disorders do not promote cognitive decline in PD

Impulse control disorders do not promote cognitive decline in PD

Creatine monohydrate disappoints in Parkinson’s disease

Creatine monohydrate disappoints in Parkinson’s disease

Perceived cost affects placebo response in Parkinson’s disease

Perceived cost affects placebo response in Parkinson’s disease

Creatine monohydrate disappoints in Parkinson’s disease

Creatine monohydrate disappoints in Parkinson’s disease

Childhood macroprolactinomas amenable to dopamine agonist treatment

Childhood macroprolactinomas amenable to dopamine agonist treatment

Newron, Zambon announce re-submission of safinamide NDA to FDA

Newron, Zambon announce re-submission of safinamide NDA to FDA

Non-ergot derived dopamine agonists may be safe for the heart

Non-ergot derived dopamine agonists may be safe for the heart

Naltrexone may be effective in diminishing ICD symptoms in PD patients, study finds

Naltrexone may be effective in diminishing ICD symptoms in PD patients, study finds

Newron Pharmaceuticals submits safinamide NDA to FDA

Newron Pharmaceuticals submits safinamide NDA to FDA

Study: Depression in Parkinson's patients may reflect impaired striatal dopamine function

Study: Depression in Parkinson's patients may reflect impaired striatal dopamine function

Depression in Parkinson's disease people associated with reduced dopamine synthesis capacity

Depression in Parkinson's disease people associated with reduced dopamine synthesis capacity

Drugs often fail to bring acromegaly under control in routine clinical practice

Drugs often fail to bring acromegaly under control in routine clinical practice

Neuroscientists honored for research into brain's reward and decision-making systems

Neuroscientists honored for research into brain's reward and decision-making systems

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Teva to present abstracts on AZILECT at MDS meeting

Teva to present abstracts on AZILECT at MDS meeting

Promising studies for Parkinson's to be presented at 65th AAN meeting

Promising studies for Parkinson's to be presented at 65th AAN meeting